FILTER

Refine your search with the following facets to narrow down your results.

4 Current news of DNage

Pharming completes spin-off of DNage

21-Jul-2010 - Biotech company Pharming Group NV announced that, following the settlement agreement of May 2010 with the former DNage shareholders, which agreement initiated the spin-off of DNage, the spin-off has now become definitive. In May 2010, Pharming announced the initiation of the spin-off of its ...

Dnage to Participate in European Study on Biomarkers of Ageing

16-Jul-2008 - Biotech company Pharming Group NV announced that its wholly owned subsidiary DNage is participating in a large European study, called MARK-AGE, to identify and establish biomarkers of human ageing. Under the Seventh Research Framework Programme (FP7), the European Union has allocated a total ...

ageing biomarkers diseases +3

Pharming receives funding for development of new treatments for premature ageing diseases

29-Jan-2008 - Pharming Group NV announced that its wholly owned subsidiary DNage will head a collaborative Research and Development effort to identify novel biomarkers and therapeutic targets, and to develop therapeutics for the treatment of premature ageing diseases. The consortium has been granted a ...

ageing biomarkers diseases +2

DNage, Loders Croklaan, BG Medicine and Erasmus announce collaboration in the field of type II diabetes

02-May-2006 - DNage BV, Loders Croklaan BV, through its wholly owned subsidiary Lipid Nutrition BV ("Lipid Nutrition"), BG Medicine Inc ("BG Medicine") and the Erasmus University Medical Center ("Erasmus MC") announced the start of a collaboration to develop new products and biomarkers for type II diabetes. A ...

biomarkers nutritional products research collaborations